FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← The Wire
AAVXFNasdaq

Abivax S.A.

Pharmaceutical Preparations · I0 · CIK 1956827

Abivax develops and commercializes innovative antiviral and anti-inflammatory drugs

+ WatchView on EDGAR ↗
44
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
All6-K · 34SC 13G · 320-F · 3SC 13D/A · 2424B5 · 2SC 13D · 1424B4 · 1
SC 13D/ASC 13D/AMay 11, 2026SC 13D/ASC 13D/AJan 14, 2026

Similar companies

Comparable business profile · signals at a glance

ASMBASSEMBLY BIOSCIENCES, INC.$455.0M+0.8%VALNValneva SE$507.8M-0.4%PCVXVaxcyte, Inc.$6.9B+2.1%AVTXAvalo Therapeutics, Inc.$775.9M+6.0%ARCTArcturus Therapeutics Holdings Inc.$198.1M-0.9%RGNXREGENXBIO Inc.$344.3M+12.9%